Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, ...

Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Sanofi (NASDAQ:SNY – Free Report) – Stock analysts at Zacks Research cut their Q3 2025 earnings estimates for shares of Sanofi in a research note issued to investors on Wednesday, March 5th.

Sanofi (NASDAQ:SNY – Free Report) – Equities researchers at Zacks Research lowered their Q2 2025 earnings estimates for Sanofi in a report issued on Wednesday, March 5th. Zacks Research analyst K.

Keybank National Association OH grew its stake in Sanofi (NASDAQ:SNY – Free Report) by 9.9% during the 4th quarter, Holdings Channel reports.The fund owned 10,105 shares of the company’s stock ...

While markets sink, Regeneron Pharmaceuticals (NASDAQ:REGN) is up about 4%, or $30 on the day. Helping, the company and Sanofi (NASDAQ:SNY) just posted positive results from a pivotal ADEPT Phase ...

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against other best immunology stocks to buy now. Immunology is a rapidly advancing field with significant potential ...